Status:
RECRUITING
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18-75 years
Brief Summary
Ovarian cancer is a highly lethal gynecological malignancy, often diagnosed at an advanced stage, with high rates of recurrence within 1-2 years after frontline treatment. Current guidelines recommend...
Detailed Description
Ovarian Cancer is the deadliest gynecological malignancy, with over 70% of patients being diagnosed at advanced stages, and more than 70% experiencing recurrence within 1-2 years after frontline treat...
Eligibility Criteria
Inclusion
- Age between 18 and 75 years;
- Pathological diagnosis of high-grade serous ovarian cancer;
- Newly diagnosed ovarian cancer case without prior neoadjuvant therapy.
Exclusion
- Non-primary (recurrent) patients;
- Ovarian cancer patients who have not undergone surgical treatment;
- Patients with a history of other malignancies.
Key Trial Info
Start Date :
October 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 10 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06019923
Start Date
October 26 2023
End Date
September 10 2027
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang, China, 310000